Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Chew E.; Clemons T.; Sangiovanni J.; Danis R.; Ferris F.; Elman M.; Antoszyk A.; Ruby A.; Orth D.; Bressler S.; Fish G.; Hubbard Baker; Klein M.; Chandra S.; Blodi B.; Domalpally A.; Friberg T.; Wong W.; Rosenfeld P.; Agrón E.; Toth C.; Bernstein P.; Sperdut Robert

doi:10.1001/jama.2013.4997

← Today's brief

Study

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Chew E. et al. · JAMA · Tuesday, January 1, 2013

Read original

Funding Not reported

Source

Chew E. et al.. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. Tuesday, January 1, 2013.
doi:10.1001/jama.2013.4997

Generated, then checked claim-by-claim against the source · how this brief was built →

Physician-designed methodology · Amr Saad, MD MBA

Sign in to rate and bookmark articles

Automated evidence summary, checked against the source. Not medical advice. Verify with the original publication.